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Research
Human airway epithelia function in barrier for-
mation, defense against pathogens, and muco-
ciliary clearance (Hogg 2004). They represent 
the first barrier against airborne environmental 
pollutants, and they coordinate recruitment of 
pivotal inflammatory cells in several patholo-
gies, including chronic obstructive pulmonary 
disease (COPD) (Li et al. 2009; Mercer et al. 
2006; Yang et al. 2005). The inhalation of   diesel 
exhaust particles (DEP), produced by vehicu-
lar traffic contributing to urban smog, leads 
to serious respiratory diseases (e.g., COPD, 
emphysema, bronchial cancer, chronic asthma) 
(Torres-Duque et al. 2008). The particles’ 
carbona  ceous cores are coated with thousands 
of organics and heavy metals. Because large 
numbers of hazardous chemicals are present on 
DEP, its pathological effects on human airways 
are pleiotropic. We and others have found that 
DEP evokes the secretion of matrix metallo-
proteinase-1 (MMP-1) from human bronchial 
epithelia (Amara et al. 2007; Li et al. 2009). 
Matrix metalloproteinase-1 (MMP-1) plays a 
role in tissue remodeling during development, 
inflammation, migration of inflammatory and 
malignant cells, and COPD and emphysema 
patho  genesis (Segura-Valdez et al. 2000). It 
also has neuro  tropic effects, possibly enhancing 
sensitization of airway-innervating sensory neu-
rons, contributing to airway hypersensitization 
and chronic cough (Conant et al. 2004). We 
recently identified a novel pathway that results 
in DEP-induced MMP‑1 activation and entails 
activation of RAS-RAF-MEK-extracellular 
  signal–regulated kinase (ERK) signaling, depen-
dent on β-arrestins (Li et al. 2009). From a 
global health perspective, one important find-
ing was that the human MMP‑1 polymorphism 
at position –1607(1G/2G) of the MMP‑1 pro-
moter yielded, after DEP exposure, either a 
diminutive (1G) or large (2G) response. The 
2G poly  morphism is found in 75% of humans. 
Against this background, we sought to 
identify critical elements upstream of RAS 
in human airways in response to DEP. The 
pathogenic component of DEP that activates 
MMP‑1 is primarily retained in its organic 
extract (OE), such that DEP carbonaceous 
core particles shuttle water-insoluble OE to 
the ciliary plasma membrane. The DEP/OE 
initially activates proteinase-activated recep-
tor 2 (PAR-2), which, via Gi/o G-protein, 
phospholipase-Cβ3 (PLCβ3), and phos-
phatidylinositol 3 kinase (PI3-K), activates 
Ca2+-permeable TRPV4 (transient receptor 
potential vanilloid, family member 4) ion 
channels (Liedtke et al. 2000; Lorenzo et al. 
2008; Sidhaye et al. 2008; Strotmann et al. 
2000). A uniquely protracted Ca2+ influx 
through TRPV4 follows, which is critical for 
mitogen-activated protein kinase (MAPK)–
mediated MMP‑1 activation. Localization 
studies show that PAR-2, PLCβ3, and TRPV4 
colocalize to cilia of human differentiated air-
way epithelia. DEP exposure greatly enhances 
protein–protein complex formation between 
these signaling molecules and calmodulin. 
Importantly, we observed that TRPV4P19S, 
a human genetic polymorphism previously 
identified as a COPD susceptibility locus (Zhu 
et al. 2009), increases MMP‑1 activation via 
increased Ca2+ influx, providing a mechanistic 
link between human airway epithelia signaling, 
airway disease, and air pollution.
Materials and Methods
DEP. Particles were generated at the U.S. 
Environmental Protection Agency (EPA; 
Research Triangle Park, NC) from a Deutz 
four-cylinder diesel engine, running at 
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Ba c k g r o u n d: Human respiratory epithelia function in airway mucociliary clearance and barrier 
function and have recently been implicated in sensory functions. 
oB j e c t i v e: We investigated a link between chronic obstructive pulmonary disease (COPD) patho-
genesis and molecular mechanisms underlying Ca2+ influx into human airway epithelia elicited by 
diesel exhaust particles (DEP).
Me t h o d s  a n d re s u l t s: Using primary cultures of human respiratory epithelial (HRE) cells, we 
determined that these cells possess proteolytic signaling machinery, whereby proteinase-activated 
receptor-2 (PAR-2) activates Ca2+-permeable TRPV4, which leads to activation of human respira-
tory disease–enhancing matrix metalloproteinase-1 (MMP-1), a signaling cascade initiated by diesel 
exhaust particles (DEP), a globally relevant air pollutant. Moreover, we observed ciliary expression 
of PAR-2, TRPV4, and phospholipase-Cβ3 in human airway epithelia and their DEP-enhanced 
protein–protein complex formation. We also found that the chronic obstructive pulmonary disease 
(COPD)–predisposing TRPV4P19S variant enhances Ca2+ influx and MMP 1 activation, providing 
mechanistic linkage between man-made air pollution and human airway disease. 
co n c l u s i o n: DEP evoked protracted Ca2+ influx via TRPV4, enhanced by the COPD-predisposing 
human genetic polymorphism TRPV4P19S. This mechanism reprograms maladaptive inflammatory 
and extra  cellular-matrix–remodeling responses in human airways. The novel concept of air pollu-
tion–responsive ciliary signal transduction from PAR-2 to TRPV4 in human respiratory epithelia 
will accelerate rationally targeted therapies, possibly via the inhalatory route.
key w o r d s : air pollution, COPD, DEP, human bronchial epithelia, MMP-1, PAR-2, PI3-kinase, 
PLCβ3, TRPV4, TRPV4P19S. Environ Health Perspect 119:784–793 (2011).  doi:10.1289/
ehp.1002807 [Online 18 January 2011]DEP activates airway PAR-2 TRPV4 Ca2+ signaling
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three defined engine loads before collec-
tion, as described previously (Li et al. 2009). 
For experiments, we used DEP at 100 μg/
mL. DEP organic extract (OE) was pre-
pared by washing organic chemicals off of 
DEP using methylene chloride, followed by 
solvent exchange with dimethyl sulfoxide 
(DMSO). In experiments, we used 20 μg/mL   
OE, which is equivalent to the organic com-
pounds contained in 100 μg DEP. We used 
Degussa Printex 90 carbon nanospheres (P90; 
provided by W. Moeller, GSF, Munich, 
Germany) as controls. 
Chemicals. We used the following com-
pounds: pertussis toxin (Gi/o inhibitor; Sigma 
Chemical Co., St. Louis, MO), U73122 (PLC 
inhibitor; Tocris, Ellisville, MO), LY294002 
and PI828 (PI3-K inhibitors; Tocris), 
4α-phorbol 12,13 didecanoate (4α-PDD; 
TRPV4 activator; Tocris), GSK205 [TRPV4 
blocker (Phan et al. 2009)], ruthenium red 
[TRP(V) blocker; Tocris], gadolinium(III) 
chloride [GdCl3 (Sigma); inhibitor of store-
operated calcium entry (SOCE) at 5 μM 
(Bird et al. 2008)], thapsigargin (Ca2+-store 
depletion; Tocris), GM1489 and Z-PDLDA-
NHOH (pan-MMP inhibitors; Endogen, 
Rockford, IL), and W-7 (calmodulin blocker 
at 10 μM; Sigma). 
Cell culture. BEAS-2B cells were obtained 
from ATCC (Rockville, MD), maintained 
as previously described (Li et al. 2009), and 
used for stimulation with DEP or OE and 
for all DNA and small interfering RNA 
(siRNA) transfection experi  ments. Primary 
human bronchial epithelial (HBE) cells were 
tracheo  bronchial cells derived from healthy, 
non  smoking adult volunteers. We obtained 
institutional review board approval for this 
study from the participating institutions, and 
volunteer donors provided informed consent 
for use of the cells in research. Additional details 
on cell culture are available in Supplemental 
Material (doi:10.1289/ehp.1002807).
MMP‑1 reporter gene assays were con-
ducted as described previously (Li et al. 2009). 
A set of MMP‑1 promoters of different lengths 
was available for both human polymorphisms, 
–1607G and –1607GG.
siRNA was transfected into BEAS-2B cells 
following previously published methods (Li 
et al. 2009). siRNA was directed against PAR-2, 
PAR-1, β-arrestins 1 and 2, and TRPV4. 
Scrambled controls were used as provided by 
the manufacturer (Dharmacon, Lafayette, CO). 
siRNA efficiency was confirmed by quantitative 
reverse-transcriptase polymerase chain reaction 
(PCR) and Western blotting. 
TRPV3 and TRPV4 dominant-negative 
(DN) isoforms were generated by isolating a 
truncated form of each channel, from 10 amino- 
acids N-terminal to the fifth trans  membrane 
domain to 10 amino-acids C-terminal to the 
sixth transmembrane domain. In addition, two 
point mutations were generated as M680K and 
D682K for TRPV4 and as L619K and D621K 
for TRPV3 in order to render the channel frag-
ments Ca2+ impermeable. Both of these con-
structs were C-terminally fused to monomeric 
red fluorescent protein (RFP).
Dominant-negative isoforms of STIM1 
and ORAI1, -2 and -3 were provided by 
L. Birnbaumer and S. Muallem. These cDNAs 
were driven by CMV promoters in eukaryotic 
expression plasmids, the coding region fused to 
eGFP. DN-STIM1 and DN-ORAI1-3 have 
been shown to specifically interfere with func-
tion of their cognate wildtype isoforms and 
inhibit them. Enzyme-linked immunosorbent 
assays (ELISAs) for MMP-1, RANTES (regu-
lated on activation, normal T-expressed and 
secreted), and IP-10 (interferon-γ–induced 
protein 10 kDa, CXCL10) were conducted 
using commercially available kits. For MMP-1 
secretion, we previously demonstrated its cor-
relation to the specific proteolytic activity of 
MMP-1 (Li et al. 2009).
Ca2+ imaging of BEAS-2B cells was con-
ducted using 2 μM fura-2 acetoxy  methyl ester 
for loading and following a protocol for ratio-
metric Ca2+ imaging using 340/380 nm blue 
light for dual excitation, recording emissions 
with specific filter sets. Ratios of the emissions 
were acquired every 5 sec. ∆R/R0 is the fraction 
of the increase of a given ratio over the baseline 
ratio, divided by baseline ratio. For stimula-
tion of cells with DEP, we used particles at 
100 μg/mL and analyzed only cells with micro-
scopically verified contact with particles. For 
stimulation with OE, all cells were analyzed. 
To stimulate TRPV4, hypotonicity was used 
at 260 mOsmol/L, and 4α-PDD at 10 μM; 
Ca2+ stimulation was accomplished by switch-
ing from 0 to 2 mM. Ca2+ imaging of primary 
HBE cells was conducted by excising the air–
liquid interface matrix with a scalpel and affix-
ing it to the opening of a glass-bottom dish, 
with other procedures as for BEAS-2B cells.
Electrophysiological recordings. Extracellular 
Ca2+ was precipitated by addition of EGTA. 
We conducted PI3-K Förster resonance energy 
transfer (FRET) imaging based on FRET of 
membrane-targeted enhanced green fluores-
cent protein (eGFP; donor) and the pleckstrin 
homology domain of Bruton’s tyrosine kinase, 
fused to mCherry fluorescent protein (acceptor). 
With low phosphatidyl  inositol (3,4,5)-trisphos-
phate (PIP3) levels, the mCherry is cytoplasmic; 
with increased PIP3 levels, it trans  locates to the 
membrane leading to FRET, which we quan-
tified using two-photon fluorescence lifetime 
imaging. Additional details for electro  physio-
logi  cal recordings are given in Supplemental 
Material (doi:10.1289/ehp.1002807). 
The phosphorylated ERK (phospho-ERK) 
trafficking assay was performed as described 
previously (Li et al. 2009). Briefly, BEAS-2B 
cells were stimulated either with DEP or with 
OE and fixed (4% paraformaldehyde) at 5-, 
10-, 20-, and 30-min time points. Phospho-
ERK1/2 was verified by fluorescent immuno-
detection and quantified densitometrically 
(≥ 75 cells/time point), corrected for back-
ground, in the nuclear area using ImageJ soft-
ware (version 1.42q; Rasband 2009).
Confocal imaging was conducted after 
immuno  cytochemical staining for acetylated 
α-tubulin, PLCβ3, TRPV4, and PAR-2. 
Fluorescently labeled sections were visualized 
using a Zeiss LSM710 confocal imaging suite 
with lasers tuned to the emission spectra of 
the secondary fluorescent anti  bodies.
Coimmunoprecipitation studies were con-
ducted using 106 BEAS-2B cells per experi-
ment; cells were harvested in lysis buffer (1% 
NP40 detergent). Exactly 100 μg protein 
was incubated with rabbit anti–PLC-β3, rab-
bit anti-TRPV4, or mouse mono  clonal anti–
PAR-2 over  night at 4°C, and then solutions 
were exposed to 15 μL protein-A/G-Sepharose 
for 4 hr (4°C). After stringency washing, com-
plexes were investigated by Western blotting 
using antibodies specific for TRPV4, PAR-2, 
or calmodulin. Normal rabbit or mouse isotype 
anti  bodies were used as controls. Western blot-
ting was performed following standard method-
ology with chemoluminescence detection.
Statistical analysis. We compared mean 
and SE of quantified outcome parameters 
after stimulation with their respective con-
trols. Group comparisons were performed 
using Student’s t-test or analysis of variance 
with post hoc Scheffe test for multi  group 
comparison, applying the statistics program 
StatPlus:mac (AnalystSoft, Vancouver, British 
Columbia, Canada). Minimum significance 
was set at p < 0.05.
Results
The OE of DEP contains the active compo‑
nent to activate MMP-1. To understand 
which component(s) of DEP activate MMP‑1, 
we investigated effects of DEP and its OE in 
human BEAS-2B and primary HBE cells, 
the latter exposed at air–liquid interface [see 
Supplemental Material, Figure 1 (doi:10.1289/
ehp.1002807)]. Our findings suggest that the 
carbonaceous core of DEP, by size a carbon 
nanoparticle, acts as a vehicle carrier for deliv-
ery of the highly active, water-insoluble organic 
fraction to the plasma membrane of human 
airway epithelia to elicit MMP‑1 activation. 
Extracellular Ca2+ influx is necessary for 
activation of MMP-1. Previous studies in 
lung cells and neurons have shown that partic-
ulate matter evokes Ca2+ transients (Agopyan 
et al. 2004); other studies have shown that 
Ca2+ increases activated RAS (Lee and Yasuda 
2009) and that DEP activates RAS (Li et al. 
2009). Therefore, we examined whether DEP 
and/or OE causes Ca2+ influx and whether 
this can activate MMP‑1.Li et al.
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We found that DEP and OE evoke extra-
cellular Ca2+ influx (Figure 1A–D), as indi-
cated by curtailing of the response by addition 
of EGTA (Figure 1C,D). P90 control carbon 
nanoparticles had no effect on Ca2+ (Figure 1B), 
whereas DEP activated a uniquely protracted 
and monotonically increasing response with 
a peak at approximately 60 min that gradu-
ally declined (data not shown). In comparison, 
the response to OE increased more rapidly, 
reaching a maximum at approximately 20 min 
and decreasing to baseline in the next 10 min 
(Figure 1B), indicating that the particle core 
retarded Ca2+ influx by slowing delivery of the 
organic fraction to the plasma membrane. 
To determine whether DEP-induced Ca2+ 
influx was necessary for transcriptional activa-
tion of MMP‑1, we exposed cells to DEP in the 
presence and absence of extra  cellular Ca2+ and 
meas  ured MMP‑1 transcriptional activation 
at 2 and 24 hr and the appearance of nuclear 
phospho-ERK at 30 min (Figure 1E–I). These 
experiments indicated that extra  cellular Ca2+ 
was necessary for both nuclear trans  location 
of phospho-ERK and MMP‑1 activation in 
response to DEP or OE. In primary HBE 
cells, EGTA eliminated MMP-1 secretion in 
response to DEP or OE (Figure 1H), thus con-
firming the validity of this mechanism. 
We were unable to demonstrate function-
ality of SOCE in DEP/OE–evoked Ca2+ influx 
[see Supplemental Material, Figure 2A–C 
(doi:10.1289/ehp.1002807)]. Preincubation 
with 5 μM thapsigargin or 5 μM GdCl3 
(Bird et al. 2008) did not markedly change 
DEP-evoked Ca2+ increase. Furthermore, 
co  transfection of STIM1-DN and ORAI1-
3–DN, both known to function in SOCE, did 
not significantly alter Ca2+ responses evoked 
by DEP or OE. 
Finally, we found that DEP and OE also 
caused the Ca2+-dependent secretion of pro  -
inflammatory mediators RANTES (Jeffery 
2004) and IP-10 (Torvinen et al. 2007) 
[see Supplemental Material, Figure 2D,E 
(doi:10.1289/ehp.1002807)]. Thus, in human 
lung cells, Ca2+ influx is necessary for DEP/
OE–evoked activation of MMP‑1, IP‑10, and 
RANTES.
PAR‑2 is a DEP‑sensitive G‑protein–
coupled receptor (GPCR) that activates Gi/o, 
PLCβ3, and PI3‑K. We focused on PAR-2 
because an earlier low-throughput proteom-
ics screen revealed that, compared with DEP 
alone, DEP plus PAR-2–activating peptide 
(PAR-2-AP) increased MMP-1 secretion (data 
not shown). We first conducted experi  ments 
in BEAS-2B cells by siRNA-mediated knock-
down of PAR-2. PAR‑2 mRNA was signifi-
cantly reduced by PAR-2 siRNA but not by the 
scrambled control [see Supplemental Material, 
Figure 3A (doi:10.1289/ehp.1002807)]. Cells 
treated with PAR-2 siRNA exhibited signifi-
cantly reduced Ca2+ influx, MMP‑1 reporter 
gene activation, and MMP-1 secretion 
(Figure 2A; see also Supplemental Material, 
Figure 3B,C). This demon  strates that PAR-2 
functions upstream of Ca2+-mediated MMP‑1 
activation. In addition to scrambled siRNA 
controls, PAR-1–specific siRNA had no effect 
on MMP‑1 activation (data not shown).
Costimulation of BEAS-2B and primary 
HBE cells with DEP or OE and PAR-2-AP 
potentiated MMP‑1 activation [Figure 2B; 
see also Supplemental Material, Figure 3D,E 
(doi:10.1289/ehp.1002807)]. To boost its 
moderate expression level in BEAS-2B cells, 
we over  expressed PAR-2. This led to increased 
baseline and DEP-evoked MMP‑1 activation, 
indicating that PAR-2 over  expression is suf-
ficient to increase MMP‑1 expression and to 
render the cell more responsive to DEP (see 
Supplemental Material, Figure 3F). Thus, spe-
cific activation and inhibition of PAR-2 imply 
that this receptor is critical in DEP-mediated 
Ca2+ influx that leads to MMP‑1 activation.
We next investigated whether secreted 
MMP-1 activates PAR-2 proteolytically, as 
Figure 1. Ca2+ influx is required for DEP or OE to evoke MMP‑1 secretion. (A) Fura‑2 Ca2+ imaging in BEAS‑2B 
cells exposed to 100 μg/mL DEP at 0, 30, and 60 min (bar = 20 μm). (B) Ca2+ response (ΔR/R0 vs. time) to DEP 
(n = 43), OE (n = 62), and P90 control particles (n = 48 in BEAS‑2B cells). Note the protracted time course of 
the Ca2+ signal, in particular with DEP versus OE. (C) Rapid reduction in DEP‑induced Ca2+ signal in BEAS‑2B 
cells, after the extracellular addition of the Ca2+ chelator EGTA (2 mM) (n = 32). (D) In BEAS‑2B cells, 
response to DEP in the absence or presence of extra  cellular Ca2+; note the rapid increase in fluorescence 
upon addition of 2 mM CaCl2 (n = 19). (E) Detection of nuclear phospho‑ERK1/2 in response to DEP and OE 
depends on presence of extra  cellular Ca2+ (indicated by the lack of response after OE + EGTA treatment in 
BEAS‑2B cells). Note the statistically significant levels of increase for DEP and OE compared with controls 
(n ≥ 75 cells for each condition; 30‑min time point); two representative micrographs are depicted as insets. 
(F and G) In BEAS‑2B cells, DEP‑induced transcriptional activation of MMP‑1 depends on external Ca2+, as 
detetermined using 1G and 2G polymorphisms in the firefly luciferase reporter assay (fLUC) at 2‑hr (F) and 
24‑hr (G) time points; note the statistically significant reduction at the 2‑hr time point (F) for the –1607GG (2G) 
polymorphism compared with the –1607G (1G) polymorphism. (H) In BEAS‑2B cells, DEP‑induced secretion 
of MMP‑1 is eliminated in the presence of 2 mM EGTA. (I) In HBE cells, DEP‑induced secretion of MMP‑1 is 
eliminated in the presence of 2 mM EGTA. Note the different y‑axis scale in H and I. 
**p < 0.01, and #p < 0.001. 
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it does for PAR-1 (Boire et al. 2005), which 
might explain the protracted Ca2+ influx 
in response to DEP. This was not the case, 
because MMP inhibitors accelerated MMP‑1 
reporter gene activity in response to DEP 
[see Supplemental Material, Figure 3G 
(doi:10.1289/ehp.1002807)].
We addressed whether β-arrestins are 
necessary for PAR-2–mediated Ca2+ influx 
in response to DEP or OE (Cottrell et al. 
2003). This was not the case in view of Ca2+ 
increase in the absence of β-arrestins 1 and 2 
[siRNA-mediated knockdown; see Supplemental 
Material, Figure 3H (doi:10.1289/ehp. 
1002807)]. We previously verified elimina-
tion of MMP‑1 activation by siRNA-mediated 
β-arrestin knockdown (Li et al. 2009). Together, 
these results implicate β-arrestins as MAPK scaf-
folds necessary for the DEP–MMP-1 response 
yet dispensable for PAR-2–mediated Ca2+ influx 
in response to DEP or OE. 
We examined Gi/o signaling because of 
PAR-2’s known signal transduction mecha-
nisms via this G-protein (Olianas et al. 2007). 
We found that the DEP–MMP-1 response, 
namely, Ca2+ influx, MMP‑1 transcription, 
and MMP-1 secretion, depends on Gi/o, 
which we targeted specifically with pertussis 
toxin in both BEAS-2B and primary HBE 
cells [Figure 2A,B; see also Supplemental 
Material,  Figure  4A  (doi:10.1289/
ehp.1002807)]. Because Gi/o is known to acti-
vate PLC (Exton 1996), we next treated cells 
with PLC-selective inhibitor, U73122, which 
led to a marked DEP–MMP-1 response 
(Figure 2A,B; see also Supplemental Material, 
Figure 2. Signal transduction in response to DEP or OE involves PAR‑2, Gi/o, and PLCβ3. (A) In BEAS‑2B cells, Ca2+ response (ΔR/R0 vs. time) to OE is signifi  cantly 
attenuated with PAR‑2 siRNA [for proof of efficiency, see Supplemental Material, Figure 3A (doi:10.1289/ehp.1002807)], pertussis toxin (PTX; Gi/o inhibitor), the PLC 
inhibitor U73122, and the PI3‑K inhibitor LY294002 (n ≥ 50 cells per condition). (B) In primary HBE cells, modulation of these pathways affects MMP‑1 secretion; 
PAR‑2 gain of function potentiates the response, whereas inhibition of Gi/o, PLC, and PI3‑K significantly attenuates/eliminates it. For results in BEAS‑2B cells, includ‑
ing PAR‑2 gain and loss of function (siRNA), plus all other pathways, see Supplemental Material, Figures 3 and 4 (doi:10.1289/ehp.1002807). (C) Increase in phospho‑
PLCβ3 in response to DEP shown by representative confocal micrographs of immuno  labeled primary HBE cells (top; bar = 5 μm) and densitometry (bottom; n ≥ 50 
cells per time point). Results show the phospho‑PLCβ3 increase peaking at 30 min and decreasing at 60 min. (D) PI3‑K activity in live transfected BEAS‑2B cells 
shown by real‑time imaging in response to OE using a novel FRET‑based methodology. FRET measurements are shown in micrographs (top; bar = 4 μm), reiterat‑
ing that PI3‑K activity resides in the plasma membrane. The time course of PIP3 generation (bottom) shows that FRET generated by membrane‑targeted eGFP and 
mCherry‑tagged pleckstrin homology domain of Bruton’s tyrosine kinase increases robustly after application of OE and became significantly attenuated in response 
to subsequent application of the specific PI3‑K inhibitor LY294002 (10 μM). The graph (bottom) shows the time course of the change in PIP3 evoked by OE (quantified 
at the membrane) and its attenuation by preincubation with another specific PI3‑K inhibitor, PI828 (50 μM). 
*p < 0.05, and #p < 0.001 compared with the 0‑min time point. 
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Figure 4B). PLC has several isoforms; we 
investigated the β-isoforms because of PLCβ’s 
link to GPCRs, specifically PLCβ3, in view 
of its previously established link to Gi/o 
(Senyshyn et al. 1998). When we immuno-
labeled for PLCβ1–4, we found the most 
robust expression for PLCβ3 in primary HBE 
cells (data not shown). Interestingly, using a 
phospho-specific antibody against PLCβ3, we 
documented phospho-PLCβ3 up-  regulation 
within 30 min after DEP application 
(Figure 2C). This finding can help explain 
the protracted Ca2+ influx because PLCβ3, 
being upstream of extra  cellular Ca2+ influx, 
was previously demon  strated to be attenuated 
by phosphorylation (Yue et al. 2000).
Another phospholipid-metabolizing 
enzyme that signals downstream of Gi/o and 
upstream of TRP channel Ca2+ conductances 
is PI3-K (Zhuang et al. 2004). We identi-
fied its critical role in response to DEP or OE 
using the PI3-K inhibitor LY294002 by docu-
menting significant reduction of Ca2+ influx 
and subsequent MMP‑1 activation in both 
BEAS-2B and primary HBE cells [Figure 2D; 
see also Supplemental Material, Figure 4C 
(doi:10.1289/ehp.1002807)], suggesting the 
signaling position of PI3-K upstream of Ca2+ 
influx. Moreover, using a novel FRET-based 
assay, we could visualize the enzymatic activ-
ity of PI3-K (change in PIP3) in BEAS-2B 
cells in response to DEP or OE, which indi-
cated PI3-K activity as an early signaling event 
(Figure 2D). Furthermore, in addition to 
time-scale resolution after DEP or OE expo-
sure, this method illustrates the confinement 
of PI3-K signaling to the plasma membrane.
TRPV4 forms a DEP‑sensitive Ca2+ path‑
way downstream of PI3‑K/PLC‑β3. PAR-2 has 
been shown to sensitize TRP channels, includ-
ing TRPV1, TRPV4, and TRPA1 (Amadesi 
et al. 2006; Gatti et al. 2006; Grant et al. 
2007). Because TRPV4 is expressed in tracheo-
bronchial epithelia (Lorenzo et al. 2008), we 
addressed whether it functions downstream of 
the above signaling cascade, initially by inhib-
iting its function in BEAS-2B cells express-
ing TRPV4-DN [see Supplemental Material, 
Figure 5A–C (doi:10.1289/ehp.1002807)], 
which produced strong reduction of Ca2+ 
influx in response to DEP yet no reduction for 
TRPV3-DN (Figure 3A). We also knocked 
down TRPV4 using specific siRNA, which 
effectively down-regulated TRPV4 mRNA 
and protein (see Supplemental Material, 
Figure 5B,C). Compared with the scrambled 
control, the siRNA-TRPV4 knockdown 
reduced Ca2+ influx in response to DEP or 
OE (Figure 3B). Thus, TRPV4 is necessary for 
DEP-evoked Ca2+ influx.
Next we addressed whether DEP-evoked, 
TRPV4-mediated Ca2+ influx activates 
MMP‑1. Using MMP‑1 reporter assays, we 
found that TRPV4-specific siRNA decreased 
MMP‑1 transcriptional activation, thus 
implying that TRPV4 is critical for DEP/
OE–evoked Ca2+ influx, which then acti-
vates MMP‑1 [see Supplemental Material, 
Figure 5D (doi:10.1289/ehp.1002807)]. 
Based on these results, we used the MMP‑1 
reporter platform to determine that TRPV4 
functions downstream of PAR-2 because 
siRNA-mediated TRPV4 knockdown virtually 
eliminated potentiated MMP‑1 activation by 
DEP or OE plus PAR-2-AP (see Supplemental 
Material, Figure 5E). This effect of TRPV4-
specific siRNA was recapitulated for DEP-
evoked MMP-1 secretion in BEAS-2B cells 
(Figure 3C). Finally, we found that ruthenium 
red, an unspecific TRP(V) blocker, decreased 
MMP‑1 activation (see Supplemental Material, 
Figure 5F).
TRPV4 activation by 4α-PDD or hypo-
tonicity strongly increased MMP-1 secretion, 
indicating that in airway epithelia, TRPV4 
activation is sufficient to up-regulate MMP‑1 
(Figure 3D). Furthermore, TRPV4 trans-
fection in BEAS-2B cells increased MMP‑1 
Figure 3. TRPV4 channels are critical for DEP‑evoked MMP‑1 activation and function downstream of PAR‑2. 
Abbreviations: +, with; –, without. (A) The DEP‑evoked Ca2+ response in BEAS‑2B cells was significantly 
and specifically attenuated by inhibition of TRPV4 upon transfection of cells with RFP‑tagged TRPV4‑DN 
(n = 33) and unaffected by transfection with TRPV3‑DN [n = 44; see also Supplemental Material, Figure 4A 
(doi:10.1289/ehp.1002807)]. (B) TRPV4 loss of function is illustrated by robust inhibition of OE‑evoked Ca2+ 
responses in BEAS‑2B cells transfected with TRPV4 siRNA compared with transfection with scrambled 
control siRNA; for proof of efficiency of TRPV4 siRNA, see Supplemental Material, Figure 5B,C. (C) siRNA‑
mediated TRPV4 knockdown in BEAS‑2B cells virtually eliminated MMP‑1 activation, thus confirming that 
TRPV4 functions downstream of PAR‑2; note the elimination of MMP‑1 secretion in response to DEP or DEP 
plus PAR‑2‑AP when TRPV4 is knocked down with TRPV4 siRNA. (D) TRPV4 activation is sufficient to acti‑
vate MMP‑1 hypotonicity (HYPO; 260 mosmol/L) and the specific TRPV4 activator 4α‑PDD (10 μM) induced 
MMP‑1 secretion from BEAS‑2B cells. (E) Specific inhibition of TRPV4 with GSK205 led to dose‑dependent 
reduction of DEP‑evoked Ca2+ responses in primary HBE cells. (F) Specific inhibition of TRPV4 with GSK205 
led to a significant reduction of DEP‑evoked MMP‑1 secretion in primary HBE cells; note the increasing 
effect with increasing dose. 
*p < 0.05, **p < 0.01, and #p < 0.001. 
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reporter activation. Because these findings 
were obtained in the BEAS-2B cell line, 
we also tested TRPV4 function in primary 
HBE cells. First, we were able to significantly 
attenuate the DEP-evoked Ca2+ response by 
GSK205, a specific small-molecule TRPV4 
inhibitor (Phan et al. 2009), in a dose-de-
pendent manner (Figure 3E). In addition, 
secreted MMP-1 in response to DEP was sig-
nificantly reduced by two concentrations of 
GSK205 (Figure 3F). Thus, the cornerstones 
of TRPV4’s involvement in the DEP–MMP‑1 
response, namely, dependence of the Ca2+ 
response and MMP-1 secretion on TRPV4, 
were recapitulated in primary HBE cells. 
Whenever possible, we performed the same 
experiment in human primary HBE cells as in 
permanent human BEAS-2B cells.
Taken together, these findings point 
toward critical functioning of TRPV4 in Ca2+ 
influx into human airway epithelia evoked by 
DEP, a globally relevant air pollutant. 
TRPV4 signaling complex is located on 
motile cilia of primary human airway   epithelia. 
Because TRPV4 channels have been found in 
primary motile cilia of mouse tracheal epithelia 
(Lorenzo et al. 2008), we determined TRPV4’s 
sub  cellular location in human ciliated airway 
epithelia. Primary HBE cells were differenti-
ated in culture until they became ciliated. They 
showed ciliary location of TRPV4, PAR-2, 
and PLCβ3 (Figure 4). Thus, critical DEP-
responsive membrane-bound components 
Figure 4. Colocalization of ciliary marker acetylated (Ac) α‑tubulin with PLCβ3 (A) or TRPV4 (B), and colocalization of PAR‑2 with PLCβ3 (C) or TRPV4 (D) in cilia 
of primary HBE cells. Columns are as follows: green channel, anti‑mouse; red channel, anti‑rabbit; the merged image; and the the XZ‑series reconstruction. 
Confocal micrographs are top view for the first three columns, and the XZ‑series (fourth column) depicts a schematic rendering of an enlarged lateralized section. 
Bars = 10 μm. Primary HBE cells in D were not fully differentiated, showing “budding” cilia at the time of immuno  labeling. More elongated cilia were present in C, 
PAR‑2 colabeled for PLCβ3, and in A, Ac α‑tubulin colabeled for PLCβ3. Nevertheless, A–C suggest that PAR‑2 and TRPV4 colocalize to cilia of primary HBE cells. 
Ac α-tubulin PLCβ3 Merge XZ-series
PLCβ3 Merge XZ-series
TRPV4 Merge XZ-series
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Figure 5. In BEAS‑2 cells, protein–protein complex formation after exposure to DEP involves PAR‑2, PLCβ3, TRPV4, and calmodulin (which is functional in 
DEP‑evoked Ca2+ influx). (A) Representative Western blots of immuno  precipitation (IP) experiments performed pre  exposure (Pre) and 30 and 120 min after DEP 
exposure; for controls, a control antibody was used for IP. With PLCβ3 IP (top three panels), complexes formed containing TRPV4, PAR‑2, and calmodulin; after 
exposure to DEP, the protein–protein interaction increased for PAR‑2 and calmodulin. Under Pre conditions, the PLCβ3–calmodulin and PLCβ3–TRPV4 complexes 
were present and appreciable. With TRPV4 IP, complexes formed containing calmodulin; after DEP exposure both interactions clearly increase. PAR‑2 IP shows 
that PAR‑2 forms a protein–protein complex with calmodulin and that this interaction increased after DEP exposure. Potentiating effect of the specific calmodulin 
inhibitor W‑7 on DEP‑evoked Ca2+ influx (B) and MMP‑1 secretion (C). The arrow in B indicates the time of DEP exposure. 
#p < 0.001 for W‑7 DEP compared with control DEP and for W‑7 control compared with control control. 
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Figure 6. In BEAS‑2B cells, TRPV4P19S functions as a gain‑of‑function channel in response to DEP, causing increased MMP‑1 activation via influx of Ca2+. (A) Time 
course showing increased Ca2+‑facilitated activation of TRPV4P19S compared with TRPV4wt (n ≥ 24 cells per group). (B) Time course showing OE‑evoked Ca2+ 
influx in Ca2+‑free buffer (note the presence of Ca2+ in OE) followed by the addition of external Ca2+ (2 mM), which leads to accelerated Ca2+ influx for TRPV4P19S 
versus TRPV4wt. The signal of TRPV4wt declined after the peak, whereas TRPV4P19S‑transfected cells did not desensitize; the signal remained high at least dur‑
ing this observation period. Arrows in A and B indicate the time of Ca2+ or OE exposure. (C) Internal [Ca2+]i was significantly elevated in TRPV4P19S‑expressing 
BEAS‑2B cells cultured in external media containing Ca2+. (D) In keeping with Ca2+ responses shown in B, TRPV4P19S increased MMP‑1 transcriptional activation. 
First, transfection of TRPV4wt increased MMP‑1 reporter gene activation in response to OE by approximately 2‑fold. Second, transfection of TRPV4P19S strikingly 
increased baseline MMP‑1 reporter gene activation in response to OE by a factor of approximately 4–5 versus control‑transfected cells and by a factor of > 2 
versus TRPV4wt. TRPV4wt‑ and TRPV4P19S‑mediated increases were virtually eliminated with a second point mutation, M680K (selectivity‑filter block). This finding 
indicates that the effects of TRPV4wt and TRPV4P19S are mediated by an influx of external Ca2+ through the channel’s pore. (E) Validity of results and conclusions 
for MMP‑1 secretion by transfected BEAS‑2B cells. 
*p < 0.05, and **p < 0.01. 
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all localize to motile cilia of primary human 
HBE cells.
DEP‑facilitated recruitment to a 
  membrane‑associated receptor‑signaling 
multi  complex. Given the ciliary localization 
of the DEP-evoked transduction cascade, we 
asked whether these membrane-associated 
signaling molecules coaggregate in response 
to DEP or OE (Figure 5). In aggregate, 
DEP-responsive membrane-bound signal-
ing is charac  terized by a non  incremental 
inter  action between PLCβ3 and TRPV4, 
with subsequent recruitment of PAR-2 
and calmodulin caused by DEP exposure. 
Calmodulin’s response to DEP is inhibi-
tory, because specific inhibition of cal  modu-
lin with W-7 increased Ca2+ signaling and 
MMP‑1 activation (Figure 5B,C). This sug-
gests as explanatory mechanism(s) an increase 
in intra  cellular Ca2+ concentration ([Ca2+]i) 
via disinhibited TRPV4 and/or activation of 
PLCβ3, both of which have previously been 
shown to bind calmodulin. 
COPD‑associated TRPV4P19S increases 
MMP-1 activation in response to DEP or OE. 
For human TRPV4, a number of genetic poly-
morphisms enhance susceptibility for COPD; 
one of them, P19S, is located in the coding 
region (Zhu et al. 2009). In another study, 
TRPV4P19S was reported as a DN channel in 
transfected HEK cells in response to weak but 
not strong hypo  tonicity (Tian et al. 2009). 
Because our finding that DEP-evoked Ca2+ 
influx via TRPV4 causes MMP‑1 activation 
rationalizes airway injury by MMP-1 as caused 
by TRPV4 channel activity, not by DN chan-
nels, we attempted to resolve these seemingly 
contradictory concepts.
Compared with wild-type TRPV4 
(TRPV4wt), TRPV4P19S exhibited gain-
of-function effects in Ca2+ influx, patch 
clamp, MMP‑1 reporter gene activation, 
and MMP-1 secretion [Figure 6; see also 
Supplemental Material, Figure 6 (doi:10.1289/
ehp.1002807)]. For MMP‑1 transcriptional 
activation, TRPV4P19S gain-of-function 
effects were strictly dependent on Ca2+ influx. 
This was evidenced by inhibitory effects of 
TRPV4P19S/M680K, where the selectivity-filter– 
blocking M680K mutation causes Ca2+ imper-
meability, leading to elimination of gain of 
function (Figure 6D). Furthermore, Ca2+ 
influx in response to changes in Ca2+ concen-
tration and to DEP or OE were significantly 
increased in TRPV4P19S versus TRPV4wt, as 
was non  stimulated [Ca2+]i [extra  cellular Ca2+ 
concentration, 2 mM) (Figure 6A–C; see also 
Supplemental Material, Figure 6). Thus, in 
a human airway epithelium–derived cell line 
with robust similarity to primary HBE cells, 
TRPV4P19S functions as Ca2+-permeable gain-
of-function channel to hyper  activate the patho-
genic mediator gene MMP‑1 in response to the 
common air pollutant DEP.
Figure 7. Schematic overview showing effects of DEP on signaling in human ciliated airway epithelia lead‑
ing to TRPV4‑mediated Ca2+ influx. Abbreviations: β, G‑protein β; γ, G‑protein γ; C, C‑terminus of TRPV4; N, 
N‑terminus of PAR‑2; P, position 19 of TRPV4 ion channel protein proline (wild‑type); S, position 19 of TRPV4 
ion channel protein proline serine (P19S polymorphism). (A) Overview of respiratory epithelia exposed to 
airborne DEP. (Left) Apical DEP with attached OE approaching the ciliary brush, basement membrane, and 
innervating nerve endings (blue). (Right) Detailed view of cilia showing DEP core particles contacting cilia 
and delivering organic chemicals (OE; light green circles) to the plasma membrane (ciliary colocalization is 
shown in Figure 4). (B) The signaling cascade begins with activation of PAR‑2 (green); this ultimately leads 
to the influx of Ca2+ (dark green circles) via TRPV4 (blue) by GPCR signaling encompassing Gi/o, which in 
turn leads to activation of PLCβ3 and PI3‑K. PLCβ3 is phosphorylated (Phos) in response to DEP, partially 
accounting for the protracted Ca2+ response. PLCβ3 and PI3‑K then regulate Ca2+ influx through TRPV4, 
which binds calmodulin (CaM), which is enhanced by DEP exposure; the increased CaM also protracts Ca2+ 
influx. (C) TRPV4‑mediated Ca2+ entry activates RAS‑RAF‑MEK MAPK signaling (Li et al. 2009), resulting in 
reprogramming of transcriptional mechanisms that orchestrate remodeling of the extra  cellular matrix via 
activation of MMP‑1. The COPD‑susceptibility polymorphism TRPV4P19S functions as a gain‑of‑function chan‑
nel for additional Ca2+ influx and MMP‑1 activation, thus being relevant to human health.
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Discussion
We identified a novel DEP-activated signaling 
pathway in human airway epithelia that consists 
of a GPCR (PAR-2) signaling to a TRP chan-
nel (TRPV4). Specific activation of PAR-2 by 
OE leads to Ca2+ influx mediated by TRPV4 
channels, via membrane phospho  lipid signaling 
involving PLCβ3 and PI3-K. This pathway can 
be used to develop effective medical therapy 
for human airway injury caused by airborne 
particulate pollution, a well-recognized global 
health problem that contributes to develop-
ment of COPD and other respiratory illnesses. 
Regarding COPD, we identified a molecu-
lar, cellu  lar, and sub  cellular mechanism for 
how the COPD-predisposing non  synonymous 
genetic polymorphism TRPV4P19S may poten-
tiate DEP-evoked Ca2+ influx and activation of 
airway-pathogenic MMP‑1. A schematic of our 
findings is presented Figure 7.
In the context of our results, three quali-
fiers should be mentioned. First, TRPV4 may 
not be the only critical Ca2+ conductance 
that is activated. Second, regarding genera-
tion of phospho  lipid molecules with modula-
tory activity on TRPV4 (e.g., by PI3-K and 
PLCβ3), we speculate that ratios of active 
small molecules in the immediate vicinity of 
the channel are critical for channel function. 
These two aspects deserve further study. Third, 
mice do not have an MMP‑1–orthologous 
gene, thus restricting the direct translatability 
of our findings into a rodent model that is 
amenable to genetic engineering.
The critical participants of the DEP 
response, PAR-2, PLCβ3, and TRPV4, were 
localized to motile cilia of differentiated pri-
mary human respiratory epithelia. Motile cilia 
represent a cellular extension that enhances 
transfer of DEP organics to ciliary membranes 
via aero  genic exposure, given the enormous 
increase in cellu  lar surface (Figure 7A). This 
delivery mechanism can be viewed as “slow-
release” delivery of organic chemicals from 
coated particles to lipid membranes.
We also intend to address the ques-
tion of how this novel signaling pathway 
has been shaped by evolution. PAR-2 sig-
naling, as yet another variant of sensory sig-
naling (Schmidlin and Bunnett 2001), has 
evolved in respiratory cilia likely as a sentinel 
for activation by microbial proteases, such 
as granzyme and chitinase. PAR-2 signaling 
thus would have conferred survival benefits 
in host defenses of airway integrity yet has 
subsequently been hijacked by man-made air 
pollution, a detrimental turn that occurred 
very recently, during the last milli  seconds of 
the evolutionary clock.
A recently published landmark report 
showed that bitter taste receptors and PLCβ2 
localized to motile cilia of human primary 
airway epithelia (Shah et al. 2009); however, 
we found a different isoform, PLCβ3, that 
localized to respiratory cilia. Whether bitter 
taste receptor–mediated Ca2+ increase will 
trigger a different set of responses compared 
with PAR-2/TRPV4–mediated Ca2+ influx 
remains to be established. Our results in the 
present study suggest that TRPV4-mediated 
Ca2+ influx in response to DEP or OE leads to 
maladaptive, pro  pathogenic reprogramming 
of gene-regulatory mechanisms in human 
  airway epithelia.
In the novel signaling mechanism in 
human airway epithelia described here, Ca2+ 
influx is characterized by uniquely slow 
kinetics. Two possible causes for the slow 
kinetics are a) DEP-dependent PLCβ3 phos-
phorylation, and b) DEP-enhanced calmodu-
lin binding to a receptor-signaling multi  plex 
containing TRPV4 and PLCβ3 (Figures 5, 7), 
both of which attenuate signaling via known 
properties of the modified phospho  lipase or 
channel. The attractive hypothesis of prote-
olytic activation of PAR-2 by MMP-1 has not 
been not corroborated. 
This study is relevant for global human 
health because of the global presence of DEP. 
However, we also discovered a possibly novel 
mechanism of airway injury that is caused by 
DEP yet enhanced by the human COPD-
susceptibility polymorphism TRPV4P19S. 
Our identification of TRPV4P19S as a gain-of-
function Ca2+-permeable channel in a human 
respiratory epithelial cell line, in response to 
DEP, links COPD patho  genesis to patho-
logically increased Ca2+ influx into human 
airway epithelia elicited by a globally relevant 
air pollutant. Furthermore, our results imply 
that two human genetic polymorphisms are 
linked to respiratory health, TRPV4P19S and 
MMP‑1 (–1607G/GG), thus highlighting the 
concept of disease susceptibility as a function 
of genetic “makeup” combined with environ-
mental insults. Finally, we note yet another 
translational medical implication: The novel 
pathway described here can be targeted by 
inhalation of compounds that can specifi-
cally inhibit critical signaling molecules. In 
other words, although DEP injures respira-
tory epithelia via a luminal–apical unloading 
mechanism of DEP organics delivered by car-
bonaceous nano  particles, this very same route 
could become the avenue for safe and effective 
therapy now that key participants are known.
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